Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice.
Aloy B, Launay-Vacher V, Bleibtreu A, Bortolotti P, Faure E, Filali A, Gauzit R, Gilbert M, Lesprit P, Mahieu R, Meyssonnier V, Ogielska M, Romaru J, Salmon D, Alfandari S, Lemaignen A. Aloy B, et al. Among authors: bleibtreu a. Med Mal Infect. 2020 Jun;50(4):323-331. doi: 10.1016/j.medmal.2019.06.010. Epub 2019 Jul 17. Med Mal Infect. 2020. PMID: 31326299 Review.
RéJIF: The expanding network of French young infectious disease specialists.
Greigert V, Peiffer-Smadja N, Roblot F, Tattevin P, Lemaignen A, Bleibtreu A; RéJIF group, the SPILF. Greigert V, et al. Among authors: bleibtreu a. Med Mal Infect. 2020 Jun;50(4):311-312. doi: 10.1016/j.medmal.2019.10.005. Epub 2020 Apr 7. Med Mal Infect. 2020. PMID: 32276740 No abstract available.
Reform of the third cycle of medical studies: One year after, what is the record concerning infectious diseases?
Martins C, Peiffer-Smadja N, Thill P, Osei L, Sotto A, Bleibtreu A, Lemaignen A; RéJIF (Young Infectious Diseases Physicians’ Network - Réseau des jeunes infectiologues français). Martins C, et al. Among authors: bleibtreu a. Infect Dis Now. 2021 Sep;51(6):576-579. doi: 10.1016/j.idnow.2021.01.006. Epub 2021 Jan 16. Infect Dis Now. 2021. PMID: 33870887 No abstract available.
SPILF update on bacterial arthritis in adults and children.
Stahl JP, Canouï E, Pavese P, Bleibtreu A, Dubée V, Ferry T, Gillet Y, Lemaignen A, Lorrot M, Lourtet-Hascoët J, Manaquin R, Meyssonnier V, Pham TT, Varon E, Lesprit P, Gauzit R; reviewers. Stahl JP, et al. Among authors: bleibtreu a. Infect Dis Now. 2023 Jun;53(4):104694. doi: 10.1016/j.idnow.2023.104694. Epub 2023 Mar 21. Infect Dis Now. 2023. PMID: 36948248
Dual beta-lactam treatment: Pros and cons.
Guerra D, Vidal P, Paccoud O, Maillard A, Cachera L, Junot H, Gauzit R, Zahar JR, Abreu MA, Bleibtreu A. Guerra D, et al. Among authors: bleibtreu a. Porto Biomed J. 2022 Oct 24;7(5):e189. doi: 10.1097/j.pbj.0000000000000189. eCollection 2022 Sep-Oct. Porto Biomed J. 2022. PMID: 37213916 Free PMC article. Review.
French national cohort of first use of dalbavancin: A high proportion of off-label use.
Dinh A, Duran C, Pavese P, Khatchatourian L, Monnin B, Bleibtreu A, Denis E, Etienne C, Rouanes N, Mahieu R, Bouchand F, Davido B, Lotte R, Cabaret P, Camou F, Chavanet P, Assi A, Limonta S, Lechiche C, Riou R, Courjon J, Illes G, Lacassin-Beller F, Senneville E; Dalbavancin French Study Group. Dinh A, et al. Among authors: bleibtreu a. Int J Antimicrob Agents. 2019 Nov;54(5):668-672. doi: 10.1016/j.ijantimicag.2019.08.006. Epub 2019 Aug 7. Int J Antimicrob Agents. 2019. PMID: 31400471
92 results